Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.

Morgan CJ, Muetzelfeldt L, Curran HV.

Addiction. 2010 Jan;105(1):121-33. doi: 10.1111/j.1360-0443.2009.02761.x. Epub 2009 Nov 17. Erratum in: Addiction. 2010 Apr;105(4):766.

PMID:
19919593
2.

Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.

Morgan CJ, Muetzelfeldt L, Curran HV.

Addiction. 2009 Jan;104(1):77-87. doi: 10.1111/j.1360-0443.2008.02394.x.

PMID:
19133891
4.

Cognitive impairments in poly-drug ketamine users.

Liang HJ, Lau CG, Tang A, Chan F, Ungvari GS, Tang WK.

Addict Behav. 2013 Nov;38(11):2661-6. doi: 10.1016/j.addbeh.2013.06.017. Epub 2013 Jun 28.

PMID:
23899429
5.

Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later.

Uhlhaas PJ, Millard I, Muetzelfeldt L, Curran HV, Morgan CJ.

J Psychopharmacol. 2007 May;21(3):347-52.

PMID:
17591661
6.

[Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects].

Micallef J, Tardieu S, Gentile S, Fakra E, Jouve E, Sambuc R, Blin O.

Neurophysiol Clin. 2003 Jun;33(3):138-47. French.

PMID:
12909392
8.

Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users.

Morgan CJ, Riccelli M, Maitland CH, Curran HV.

Drug Alcohol Depend. 2004 Sep 6;75(3):301-8.

PMID:
15283951
9.

Effects of chronic ketamine use on frontal and medial temporal cognition.

Chan KW, Lee TM, Siu AM, Wong DP, Kam CM, Tsang SK, Chan CC.

Addict Behav. 2013 May;38(5):2128-32. doi: 10.1016/j.addbeh.2013.01.014. Epub 2013 Jan 31.

PMID:
23435274
10.

Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?

Stefanovic A, Brandner B, Klaassen E, Cregg R, Nagaratnam M, Bromley LM, Das RK, Rossell SL, Morgan CJ, Curran HV.

J Clin Psychopharmacol. 2009 Apr;29(2):124-33. doi: 10.1097/JCP.0b013e31819a4b91.

PMID:
19512973
11.

Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users.

Morgan CJ, Rossell SL, Pepper F, Smart J, Blackburn J, Brandner B, Curran HV.

Biol Psychiatry. 2006 Feb 1;59(3):265-72. Epub 2005 Sep 2.

PMID:
16140283
12.

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.

J Psychopharmacol. 2008 Jul;22(5):498-510. doi: 10.1177/0269881107081545. Epub 2008 Jan 21.

PMID:
18208910
14.

Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.

Lofwall MR, Griffiths RR, Mintzer MZ.

Exp Clin Psychopharmacol. 2006 Nov;14(4):439-49.

PMID:
17115871
15.

Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory.

Pitsikas N, Boultadakis A, Sakellaridis N.

Neuroscience. 2008 Jun 23;154(2):454-60. doi: 10.1016/j.neuroscience.2008.04.001. Epub 2008 Apr 7.

PMID:
18472348
16.

Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.

D'Souza DC, Ahn K, Bhakta S, Elander J, Singh N, Nadim H, Jatlow P, Suckow RF, Pittman B, Ranganathan M.

Biol Psychiatry. 2012 Nov 1;72(9):785-94. doi: 10.1016/j.biopsych.2012.05.009. Epub 2012 Jun 19.

PMID:
22717030
17.

Commentary on Morgan et al. (2010): ketamine abuse: first medical evidence of harms we should confront.

De La Torre R.

Addiction. 2010 Jan;105(1):134-5. doi: 10.1111/j.1360-0443.2009.02824.x. No abstract available.

PMID:
20078466
18.

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.

Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):819-27.

PMID:
12921915
19.

Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers.

Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV.

Neuropsychopharmacology. 2004 Jan;29(1):208-18.

20.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479

Supplemental Content

Support Center